how can we best sequence novel treatments in urothelial cancer?
Published 1 year ago • 52 plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
4:34
optimising treatment for advanced urothelial cancer: combination, maintenance or sequencing?
-
3:02
novel treatment options for patients with metastatic, inoperable urothelial carcinomas
-
1:18
investigating novel treatment options for bcg-unresponsive urothelial carcinoma
-
1:31
novel therapies for the treatment of bladder cancer
-
0:49
evolving landscape of urothelial cancer treatment: erdafitinib or enfortumab vedotin?
-
3:38
breakthroughs in urothelial cancer treatment at esmo 2023
-
4:47
asco 2023 highlights on erdafitinib in metastatic urothelial cancer with select fgfr alterations
-
26:08
metastatic hormone positive breast cancer | 2023 ku breast cancer year in review conference
-
4:22
vegf and egfr pathways in detail: target for new therapies against cancer
-
5:06
state of the art research in bladder cancer treatment
-
2:21
precision medicine in urothelial carcinoma
-
2:05
the evolving treatment landscape of advanced and metastatic urothelial carcinoma
-
2:35
urothelial carcinoma treatment: the future
-
2:43
treatment sequencing and combinations for prostate cancer
-
55:13
advanced/metastatic urothelial carcinoma: understanding novel immunotherapy maintenance strategies
-
56:13
advanced/metastatic urothelial carcinoma: understanding novel immunotherapy maintenance strategies
-
0:50
maintenance therapy for patients with advanced urothelial carcinoma
-
3:37
optimal treatment strategies for patients with metastatic urothelial carcinoma
-
1:23
recent advances in the use of targeted therapies for metastatic urothelial carcinoma
-
1:26
sequencing and treatment strategies in advanced urothelial carcinoma
-
2:03
current approaches to treating urothelial cancer
-
2:30
bladder cancer: unmet need for novel therapies